Author: Matthew Collom
-

U.S. Stocks Gain on U.S.-Japan Trade Deal Hopes; Tesla, Alphabet Earnings in Focus
U.S. equity markets climbed on Wednesday, buoyed by optimism surrounding a new trade agreement between the United States and Japan. Investors also turned their attention to upcoming earnings reports from tech heavyweights Tesla and Alphabet. As of 09:35 ET, the Dow Jones Industrial Average was up 245 points (0.6%), the S&P 500 gained 23 points…
-

Stock Market Today: S&P 500 Ends at Record High Despite Chip Sector Weakness
The S&P 500 closed at a new all-time high on Tuesday, although gains were modest as chip stocks stumbled and investors processed a flurry of corporate earnings reports. By the close at 4:00 p.m. ET, the Dow Jones Industrial Average rose 170 points (0.40%), and the S&P 500 edged up 0.03% to a record close…
-

Stock Market Today: S&P 500 Closes Above 6,300 for the First Time; Focus Turns to Big Tech Earnings
The S&P 500 closed above the 6,300 mark for the first time on Monday, as investors geared up for a wave of major second-quarter earnings reports set to arrive this week. Several of Wall Street’s biggest names, including tech heavyweights, are scheduled to release their results. By the 4:00 p.m. ET market close, the S&P…
-

Global Markets Weekly Update
U.S. Inflation Rises as Strong Earnings Lift Markets United States Stocks Hit New Highs on Earnings StrengthU.S. equities rallied, with the S&P 500 and Nasdaq Composite reaching fresh record highs, supported by strong corporate earnings and generally positive economic data. The small-cap Russell 2000 also posted gains, while the Dow Jones Industrial Average and S&P…
-

Stock Market Today: S&P 500 Ends Flat Amid Fresh EU Tariff Concerns
U.S. stocks finished mixed Friday, with the S&P 500 closing virtually unchanged, as renewed fears of a trade war with Europe weighed on sentiment. Despite the flat finish, the index still posted a weekly gain. At the closing bell, the Dow Jones Industrial Average slipped 142 points, or 0.3%, the S&P 500 was nearly unchanged,…
-

U.S. Stocks Edge Higher on Strong Earnings; Netflix Dips Despite Solid Results
U.S. equities saw modest gains on Friday as investors assessed a fresh wave of upbeat second-quarter earnings reports and continued signs of economic resilience, even as trade uncertainties linger. By 09:32 ET, the Dow Jones Industrial Average was up 85 points, or 0.2%, the S&P 500 added 12 points, also 0.2%, and the NASDAQ Composite…
-

Stock Market Closes at Record High as Retail Sales and Earnings Impress
The S&P 500 closed at a new record high on Thursday, buoyed by stronger-than-expected retail sales and continued positive momentum in corporate earnings. At the close of trading ,4:00 p.m. ET , the S&P 500 rose 0.6% to a record 6,300.42. The Dow Jones Industrial Average gained 230 points (0.6%), and the NASDAQ Composite advanced…
-

U.S. Stocks Edge Higher on Strong Retail Sales; Netflix Earnings in Focus
U.S. equities nudged higher on Thursday, supported by upbeat retail sales data and a wave of corporate earnings. As of 9:35 a.m. ET, the Dow Jones Industrial Average was up 100 points, or 0.2%, while the S&P 500 rose 4 points (0.1%) and the NASDAQ Composite gained 20 points (0.1%). Netflix Earnings Ahead Investor sentiment…
-

Stock Market Today: S&P 500 Rises After Trump Dismisses Powell Firing Rumors
U.S. stocks closed higher on Wednesday, with the S&P 500 edging up after President Donald Trump denied reports suggesting he was preparing to fire Federal Reserve Chairman Jerome Powell. At the close of trading, the Dow Jones Industrial Average rose by 231 points (0.5%), the S&P 500 gained 0.3%, and the Nasdaq Composite added 0.3%,…
-

Tevogen.AI Expands Platform to Accelerate Patient Matching and Speed Therapy Development
July 16, 2025 — Tevogen Bio Holdings Inc. (Nasdaq:TVGN) is doubling down on its AI capabilities following the successful launch of its proprietary PredicTcell™ platform. The company announced plans to expand its Tevogen.AI division to integrate real-world patient data, aiming to streamline clinical trial recruitment and speed time-to-market for its personalized T cell therapies. Backed…